Clarity Diagnostics Clarity 5 Panel Drugs of Abuse Dip Card (25/Box)

The Clarity 5 Panel Dip Card detects five drug classes, including four core substances and a configurable fifth panel, offering two distinct testing configurations.

Core 4 Substances Detected:

• AMP (Amphetamine)
• COC (Cocaine)
• THC (Marijuana/Hashish)
• OPI (Opiates)

Configurable 5th Panel Options:

1. PCP (Phencyclidine)
2. MET (Methamphetamine)

This device is ideal for professional settings, as it is both 510K cleared and CLIA waived, ensuring suitability for regulated screening environments. The results are also photocopiable for easy, compliant documentation.

Yes, the Clarity 5 Panel Drugs of Abuse Dip Card meets significant regulatory requirements for in-vitro diagnostic devices, making it highly versatile for professional use.

• It is both 510K cleared and CLIA waived, ensuring adherence to recognized standards.
• The CLIA waived status allows it to be used across numerous settings, including pre-employment screening, athletic compliance, occupational health centers, and clinical evaluations.

Furthermore, a key benefit for official record-keeping is that the results are photocopiable, allowing for easy integration into official documentation processes.

Yes, the Clarity Diagnostics Dip Cards are supplied in packaging suitable for frequent, professional use:

• Quantity: Each box contains 25 test cards. This bulk quantity is ideal for high-volume testing scenarios, such as employment screenings, medical evaluations, and specialized testing facilities.
• Documentation: For streamlined record-keeping, the results generated by the dip card are designed to be photocopiable.
• Compliance: The device is also 510K cleared and CLIA waived, making it compliant for use in certain regulated professional environments.

Yes, a key benefit of the Clarity 5 Panel Drugs of Abuse Dip Card is that the results are designed to be photocopiable.

This feature is essential for streamlining documentation, simplifying record-keeping, and maintaining compliant records in professional settings, including:

• Pre-employment screening
• Medical evaluations
• Legal contexts
• Athletic testing

Yes, the Clarity 5 Panel Drugs of Abuse Dip Card holds both essential regulatory clearances, confirming its reliability and suitability for professional screening environments:

• CLIA Waived: This allows the test to be easily administered in various settings, including point-of-care facilities that possess a Certificate of Waiver, simplifying the testing process.
• 510K Cleared: This confirms that the device adheres to all necessary FDA standards for safety and effectiveness as an in-vitro diagnostic tool.

These robust compliance standards make the dip card an ideal choice for pre-employment screening, routine medical evaluations, and compliance monitoring. Furthermore, results are designed to be photocopiable, which significantly aids in documentation and record-keeping.

Yes, the Clarity 5 Panel Drugs of Abuse Dip Card is explicitly engineered for swift and accurate detection of elevated drug levels in human urine.

• Rapid Screening: The straightforward dip card design allows for quick procedures and the rapid determination of screening outcomes, making it highly effective for time-sensitive uses like pre-employment or clinical assessments.
• Reliability: The test’s accuracy and utility are backed by established regulatory standards. It is both 510K cleared and CLIA waived, certifying its reliability for professional, point-of-care environments.

The Clarity 5 Panel Drugs of Abuse Dip Card provides two distinct 5-panel configurations to accommodate varying screening requirements. Both options reliably screen for the four core drug classes:

• Amphetamine (AMP)
• Cocaine (COC)
• Marijuana/Hashish (THC)
• OPI2000 (OPI)

The fifth panel substance differentiates the two available configurations:

Yes, the Clarity 5 Panel Drugs of Abuse Dip Card meets both critical regulatory requirements, ensuring reliability and suitability for professional use:

• CLIA Waived: This key status permits the test to be used in diverse point-of-care settings, such as occupational health clinics and urgent care facilities, without requiring a high-complexity laboratory environment.
• 510K Cleared: This indicates the device has received FDA clearance, confirming its safety, reliability, and effectiveness for diagnostic screening.

For easy record-keeping, the generated test results are also photocopiable, simplifying documentation for regulatory compliance and case files.

The OPI test on the Clarity 5 Panel Dip Card is designed to detect the OPI2000 drug class.

This panel screens for the presence of elevated levels of common opioid substances in the tested sample.

The Clarity 5 Panel Dip Card screens for five classes of drugs, offering two distinct configurations to meet various professional screening requirements. Both configurations always detect four core substances, with the fifth drug depending on the variant chosen.

All panels screen for:

• AMP (Amphetamine)
• COC (Cocaine)
• THC (Marijuana/Hashish)
• OPI (Opiates, specifically OPI2000)

The final substance screened is based on the configuration selected: